Esperion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.36758325
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

2.48 0.01 (0.40%)

40.67% Fall from 52W High

1.3M

XNAS Volume

XNAS 13 Mar, 2026 10:50 AM (EDT)

Board Meeting

The board meeting for Esperion Therapeutics Inc is scheduled for today, for the purpose of Esperion Therapeutics Inc Annual Report for 2025 See details

Not Eligible

Expensive Valuation

13.3 / 100

Technically Neutral

41.4 / 100

1Yr Price target upside is 177%

7 analysts

Esperion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

40.67% Fall from 52W High

SWOT Analysis

Esperion Therapeutics Inc Live Price Chart